Carlyle to take majority stake in SeQuent

0
1575
Carlyle
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Private equity firm Carlyle Group is to acquire up to 74% equity stake in animal health-focused pharma company SeQuent Scientific, for ₹15.8 billion (US$210 million).

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link